Medial temporal lobectomy is effective in improving seizure outcomes among patients with drug-resistant temporal lobe epilepsy.

In a groundbreaking discovery, scientists have found that the birth of new brain cells in adults plays a key role in verbal ...

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...

“This rare form of seizure is typically associated with abnormal activity in the brain’s frontal lobe, particularly the supplementary motor area, which is responsible for controlling motor function ...

Frontotemporal lobar degeneration (FTLD) is a neurodegenerative disease affecting the frontal and temporal lobes that regulate higher cognitive brain functions such as personality, behavior ...

Objective We sought to augment the presurgical workup of medically refractory temporal lobe epilepsy by creating a supervised machine learning technique that uses diffusion-weighted imaging to ...

Ictal asystole was the most frequently reported pattern. Ictal asystole, ictal bradycardia and ictal AV block predominantly occurred during focal dyscognitive seizures in people with temporal lobe ...

The round recognizes recent FDA alignment to advance NRTX-1001 into the Phase 3 EPIC (EPIlepsy Cell therapy) trial - The Phase 3 EPIC trial is designed as a single pivotal trial and is intended to ...

Neurona Therapeutics has gained $102m to support the advancement of its investigational cell therapy, NRTX-1001, into Phase III testing for drug-resistant mesial temporal lobe epilepsy (MTLE). The ...

Mesial temporal lobe epilepsy is the most common form of epilepsy. Credit: PonyWang via Getty Images. Neurona Therapeutics has gained $102m to support the advancement of its investigational cell ...

Some people have both generalised and focal seizures. The brain has two halves called hemispheres. Each half has four parts called lobes: the frontal, temporal, parietal, and occipital lobes.

Temporal lobe attention deficit disorder (ADD) is not a recognized medical condition. Some doctors and clinics claim that it is one of seven subtypes of attention deficit hyperactivity disorder ...